Award
NIH Reporter #5U54CA137788-17
Pilot Project 2: Comprehensive characterization of Immune Features Linked to Genetic Variants and Response to Immunotherapy
Recipient
Sloan-Kettering Institute for Cancer Research
Award Amount
$52,800.00
Ceiling
$52,800.00
Awarded
September 16, 2025
Identifier
5U54CA137788-17
This award funds a multiyear research project by the Sloan-Kettering Institute for Cancer Research to study immune features linked to genetic variants and immunotherapy response in lung cancer, supported by the National Cancer Institute.
Description
The project focuses on identifying and characterizing somatic biomarkers in lung cancer tumors. The research aims to improve clinical genomic testing and uncover therapeutic targets. The project involves immune profiling, genetic analysis, and environmental factor assessment. The funding is provided by the National Cancer Institute under the FOA PAR-23-308. The project duration is from 2008 to 2029. The award is multiyear with a total of $52,800 allocated for the current period. The organization involved is Sloan-Kettering Institute for Cancer Research in New York.